Syngene International FY26 results: ₹3,739 cr revenue

What Syngene announced to the market

Syngene International Limited has released its audited financial results for the quarter and year ended March 31, 2026. The company said the results were taken on record after a Board meeting held on April 29, 2026. Alongside the annual numbers, the Board recommended a final dividend for FY2025-26 and set a record date to determine shareholder eligibility. Syngene also disclosed that it has appointed a new statutory auditor for a five-year term. The updates were communicated to stock exchanges, with BSE cited as the source.

FY26 audited financial snapshot

For the financial year ended March 31, 2026, Syngene reported consolidated revenue of ₹3,738.7 crore. In the previous financial year, consolidated revenue stood at ₹3,642.4 crore. Profit for the year in FY26 was reported at ₹316.7 crore on a consolidated basis. The company’s communication focused on audited results for both the quarter and the full year, but it did not provide additional quarterly line items in the details shared. The revenue comparison indicates a year-on-year increase in topline between FY25 and FY26 based on the numbers disclosed.

Dividend recommendation and record date

Reflecting the Board’s stated focus on shareholder returns, Syngene recommended a final dividend of ₹1.25 per equity share for FY2025-26. The dividend is on equity shares of face value ₹10 each. The company fixed June 26, 2026 as the record date for determining eligible shareholders. Record date matters because it decides which investors’ names appear on the company’s register as of that date for the dividend payout. The company disclosure did not specify the dividend payment date in the information provided.

Board meeting outcome and compliance context

Syngene’s audited results were approved following the Board meeting convened on April 29, 2026. The meeting was stated to be in line with Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The stated agenda included approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. It also included consideration of a final dividend recommendation among routine matters. The company’s exchange communication positioned the announcements as part of standard governance and disclosure processes.

Trading window closure for insiders

The company also referenced trading window restrictions for insiders as part of its regulatory compliance framework. The trading window for dealing in Syngene securities was closed from April 1, 2026. It was stated to remain closed until the close of trading hours on May 1, 2026. The disclosure noted that this aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company’s internal code for prevention of insider trading. The timeline is linked to the period around results declaration.

Investor and analyst conference call

Syngene said it would hold a conference call for analysts and investors on April 30, 2026. The call was positioned as a follow-up to the Board meeting and results announcement. The company indicated that details of the conference call would be made available on its website closer to the scheduled event. Such calls typically help investors seek clarity on results and business updates, but the disclosure shared here did not include management commentary or guidance. The scheduled call date is the day after the Board meeting that approved the audited results.

Appointment of a new statutory auditor

Syngene also announced the appointment of a new statutory auditor. The tenure mentioned was a five-year term. No further details were included in the provided information, such as the auditor’s name or the effective start date beyond the term length. Auditor appointments are typically subject to shareholder approval as per applicable rules, but the disclosure shared here only confirms the company’s announcement of the appointment and duration.

Stock performance context provided in the disclosure

The information shared alongside the corporate update included historical stock return percentages for Syngene International. The figures listed were -1.84% (1 day), -2.81% (5 days), +3.98% (1 month), -34.27% (6 months), -29.95% (1 year), and -28.99% (5 years). These numbers provide a snapshot of market performance across timeframes, but they are not explained by the company in the details provided. The returns are presented as historical performance data rather than as a direct reaction to the audited results announcement.

Key figures and dates at a glance

What this means for shareholders

For investors, the immediate takeaways are the FY26 audited consolidated numbers, the final dividend recommendation, and the record date. Shareholders who hold the stock as per the record date process can track subsequent company communication for the payment timeline. The five-year statutory auditor appointment is also relevant from a governance standpoint, though additional specifics were not included in the provided text. With the investor call scheduled for April 30, 2026, the next set of company-provided details would typically come through that interaction and any related stock exchange filings.

Conclusion

Syngene International’s FY26 audited disclosure shows consolidated revenue of ₹3,738.7 crore and profit for the year of ₹316.7 crore, along with a recommended final dividend of ₹1.25 per share and a June 26, 2026 record date. The company also communicated insider trading window timelines and an April 30, 2026 investor call, and announced a new statutory auditor for a five-year term. The next formal milestone for investors is tracking updates around the record date and any further disclosures following the conference call.